93 studies found for:    cancer | butyrate
Show Display Options
Rank Status Study
21 Completed Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: sargramostim;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
22 Active, not recruiting Ketoconazole and Dexamethasone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ketoconazole, hydrocortisone;   Drug: Ketoconazole, dexamethasone
23 Completed Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ketaconazole;   Drug: Hydrocortisone;   Drug: Dutasteride
24 Recruiting 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: 177Lu-J591;   Drug: Ketoconazole;   Drug: Hydrocortisone;   Drug: 111In-J591
25 Completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Doxorubicin hydrochloride;   Drug: Estramustine Phosphate Sodium;   Drug: Flutamide;   Drug: Ketoconazole;   Drug: Nilutamide;   Drug: Therapeutic Hydrocortisone;   Drug: Vinblastine;   Procedure: Conventional Surgery
26 Unknown  Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: dactinomycin;   Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
27 Terminated Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel + Estramustine + Hydrocortisone;   Drug: Docetaxel + Prednisone
28 Completed Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Conditions: Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: chemotherapy;   Drug: tributyrin
29 Active, not recruiting Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Conditions: Dermatologic Complications;   Malignant Neoplasm
Interventions: Drug: spironolactone;   Other: placebo;   Other: questionnaire administration;   Drug: sunscreen;   Procedure: management of therapy complications;   Drug: doxycycline;   Drug: therapeutic hydrocortisone
30 Completed Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Condition: Rash
Interventions: Drug: minocycline; Lotion (clindamycin 2% /hydrocortisone 1%);   Drug: minocycline;   Drug: clindamycin 2% and hydrocortisone 1%,
31 Recruiting Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Conditions: Pituitary Neoplasms;   Craniopharyngiomas
Interventions: Drug: Hydrocortisone;   Drug: Prednisone
32 Completed Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thioguanine
33 Completed Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
Conditions: Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: perfosfamide;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: in vitro-treated bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: syngeneic bone marrow transplantation;   Radiation: radiation therapy
34 Completed
Has Results
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Condition: Melanoma
Interventions: Drug: Ipilimumab;   Drug: Corticosteroid: Betamethasone;   Drug: Corticosteroid: Dexamethasone;   Drug: Corticosteroid: Fludrocortisone;   Drug: Corticosteroid: Hydrocortisone;   Drug: Corticosteroid: Meprednisone;   Drug: Corticosteroid: Methylprednisolone;   Drug: Corticosteroid: Prednisolone;   Drug: Corticosteroid: Prednisone;   Drug: Corticosteroid: Triamcinolone
35 Completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myelomonocytic Leukemia (M4);   Childhood Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndromes;   Refractory Anemia;   Refractory Anemia With Excess Blasts;   Refractory Anemia With Excess Blasts in Transformation;   Refractory Anemia With Ringed Sideroblasts;   Secondary Myelodysplastic Syndromes;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: asparaginase;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Radiation: 3-dimensional conformal radiation therapy;   Biological: filgrastim;   Drug: cytarabine;   Drug: idarubicin;   Drug: dexamethasone;   Drug: thioguanine;   Drug: etoposide;   Drug: methotrexate;   Drug: cyclophosphamide;   Biological: aldesleukin;   Drug: busulfan
36 Recruiting Pituitary Steroid Study
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
37 Terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Interventions: Drug: suramin;   Drug: therapeutic hydrocortisone
38 Completed 506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Lymphoblastic Lymphoma;   T-cell Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: nelarabine;   Drug: methotrexate;   Drug: cytarabine;   Drug: therapeutic hydrocortisone
39 Completed Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: cladribine;   Drug: cytarabine;   Drug: etoposide;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
40 Completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: amsacrine;   Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years